Search by Drug Name or NDC
NDC 00023-5301-08 Restasis MultiDose 0.5 mg/mL Details
Restasis MultiDose 0.5 mg/mL
Restasis MultiDose is a OPHTHALMIC EMULSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is CYCLOSPORINE.
Product Information
| NDC | 00023-5301 |
|---|---|
| Product ID | 0023-5301_884a1d8c-14e0-464c-a6b6-bfdd7009d514 |
| Associated GPIs | 86720020001620 |
| GCN Sequence Number | 076793 |
| GCN Sequence Number Description | cyclosporine DROPS 0.05 % OPHTHALMIC |
| HIC3 | Q2C |
| HIC3 Description | OPHTHALMIC ANTI-INFLAMMATORY IMMUNOMODULATOR-TYPE |
| GCN | 42588 |
| HICL Sequence Number | 004524 |
| HICL Sequence Number Description | CYCLOSPORINE |
| Brand/Generic | Brand |
| Proprietary Name | Restasis MultiDose |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cyclosporine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | EMULSION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | CYCLOSPORINE |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA050790 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00023-5301-08 (00023530108)
| NDC Package Code | 0023-5301-08 |
|---|---|
| Billing NDC | 00023530108 |
| Package | 1 BOTTLE in 1 CARTON (0023-5301-08) / 5.5 mL in 1 BOTTLE |
| Marketing Start Date | 2016-11-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |